Martin Makary
 Martin Makary     ( surgeon, bureaucrat) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Born | Liverpool, England | |||||||||
| Nationality | • UK • US | |||||||||
| Ethnicity | Egyptian | |||||||||
| Alma mater | • Bucknell University • Thomas Jefferson University • Harvard University | |||||||||
Appointed Commissioner of Food and Drugs in April 2025, announced banning of food dyes and plan to phase out all animal testing
| ||||||||||
Martin Adel Makary is a British-American surgeon, professor, author, and medical commentator who became Commissioner of Food and Drugs in 2025.
Activities
During Covid, Makary spread propaganda about a "pandemic" requiring extraordinary measures[1] a proponent of masking[2] and jabs.[3]
As Commissioner he in 2025 announced banning of dangerous food dyes.[4]
Makary also announced a plan to begin phasing out all animal testing in drug development. The plan aims to "improve drug safety" by using alternative ways to conduct toxicology studies in the preclinical phase, through the use of AI modeling and a technology called organoids, which are lab-grown cultures of human cells that can mimic and recreate organs.[5] In addition, he wants to eliminate clinical trial requirements completely for something defined as "rare diseases". Instead, the agency would closely monitor patients on the drugs until there’s a clearer signal in the data.[6]
References
- ↑ https://www.cnbc.com/2020/03/10/dr-marty-makary-on-coronavirus-wuhan-could-happen-here.html
- ↑ https://www.nytimes.com/2020/05/14/opinion/reopen-america-coronavirus-lockdown.html
- ↑ https://www.foxnews.com/opinion/first-covid-vaccine-dose-dr-marty-makary
- ↑ https://www.bworldonline.com/health/2025/04/23/667608/us-to-phase-out-many-synthetic-food-dyes-kennedy-and-fda-head-say/
- ↑ https://www.fda.gov/media/186092/download?attachment
- ↑ https://news.bloomberglaw.com/health-law-and-business/rare-disease-industry-awaits-fda-chiefs-new-drug-pathway-plan#:~:text=Makary%20outlined%20on%20the%20Megyn,a%20randomized%20controlled%20clinical%20trial.
